Jane Street’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-11,300
Closed -$37.6K 9258
2023
Q4
$37.6K Sell
11,300
-41,700
-79% -$112K ﹤0.01% 8831
2023
Q3
$198K Buy
+53,000
New +$245K ﹤0.01% 7625
2022
Q4
Sell
-15,100
Closed -$145K 9228
2022
Q3
$145K Sell
15,100
-25,100
-62% -$254K ﹤0.01% 8419
2022
Q2
$291K Sell
40,200
-3,100
-7% -$27K ﹤0.01% 7656
2022
Q1
$559K Buy
+43,300
New +$551K ﹤0.01% 7256
2021
Q4
Sell
-26,100
Closed -$419K 10123
2021
Q3
$419K Sell
26,100
-1,600
-6% -$23.5K ﹤0.01% 7599
2021
Q2
$383K Buy
27,700
+9,900
+56% +$140K ﹤0.01% 7740
2021
Q1
$260K Buy
+17,800
New +$302K ﹤0.01% 7898

Other funds holding CHRS